Malignant Bowel Obstruction: Prokinetics, Octreotide, and Goals
Ms. P, 58, has recurrent ovarian cancer with peritoneal carcinomatosis, prior debulking, and 3 lines of chemotherapy. She now has 5 days of vomiting 8–10 times daily, colicky abdominal pain, and no flatus or stool for 4 days. CT shows small bowel obstruction with multiple transition points and ascites; there is no single surgical lesion. She is alert, PS 50%, has a nasogastric tube draining 1.5 L/day, and is receiving IV fluids. She asks for 'something for the vomiting' and wants to go home. Medications: metoclopramide 10 mg q6h (started yesterday), dexamethasone 4 mg daily, morphine 5 mg SC q4h prn (using 4 doses/day), and haloperidol 0.5 mg prn. Abdomen is distended and tympanitic; bowel sounds are high-pitched. Her daughter is her health care proxy and asks whether surgery could 'fix it.'
1. Which of her current medications is potentially harmful and why? What would you change?
Read the worked answer
Metoclopramide is a prokinetic and can increase colicky pain and vomiting in complete obstruction with multiple transition points; stop it. Start octreotide 100–300 mcg SC every 8 hours or by continuous infusion to reduce gastrointestinal secretions and vomiting; add dexamethasone 4–8 mg daily to reduce peritumoral edema. Use an anticholinergic (glycopyrrolate 0.1–0.2 mg SC q6h or scopolamine) for secretions if needed. For pain, continue morphine and titrate; avoid NSAIDs if renal function is impaired. Keep the nasogastric tube for decompression if it is providing relief, but it is not a long-term home solution; a venting gastrostomy is better for home. Monitor electrolytes and fluid balance. Explain that the goal is to reduce vomiting and pain, not to 'unblock' the bowel.
2. What options exist for definitive symptom control if medical management fails, and how do you decide?
Read the worked answer
If medical management fails, options include a venting gastrostomy for refractory vomiting, surgical exploration only if there is a single correctable lesion and performance status supports it, or endoscopic stenting for a discrete obstruction. She has multiple transition points and ascites, so surgery is unlikely to help and carries high morbidity. A venting G-tube can be placed and managed at home, allowing her to be with family. If she is not a candidate or declines, continue octreotide, dexamethasone, and antisecretory therapy; consider palliative sedation for refractory vomiting if she is imminently dying. The decision should reflect her stated wish to go home, her performance status, and the likelihood of benefit. Involve surgery and interventional radiology early.
3. Address hydration and nutrition: should she receive total parenteral nutrition?
Read the worked answer
Routine total parenteral nutrition is not recommended for malignant bowel obstruction in a patient with advanced, chemotherapy-refractory ovarian cancer and a prognosis of weeks; it does not improve quality of life and adds burden, infection risk, and cost. Hydration is also controversial: IV fluids can increase secretions and vomiting, but small-volume subcutaneous fluids (for example, 500–1000 mL/day) may relieve thirst and confusion. Offer ice chips, mouth care, and sips if tolerated. Explain that the goal is comfort rather than reversing starvation. If she chooses home, arrange hospice with a plan for SC octreotide, dexamethasone, and PRN opioids. Reassess her goals; if she changes her mind about total parenteral nutrition, revisit the decision without judgment.